Research Paper Volume 16, Issue 3 pp 2887—2907
Identification of crucial anoikis-related genes as novel biomarkers and potential therapeutic targets for lung adenocarcinoma via bioinformatic analysis and experimental verification
Figure 6. Analysis of the correlation between the risk signature and genetic mutations. (A) The top 20 driver genes with the highest alteration in the high-risk group. (B) The top 20 driver genes with the highest alteration in the low-risk group. (C) Box plot of the difference in risk score for patients with TMB. (D) Scatter plot of correlations between the TMB value and the risk score. (E, F) Scatter plot of correlations between the mRNAsi, mDNAsi and the risk score.